Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033687 (
proteinuria
)
24,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rhophilin-1
is a Rho GTPase-interacting protein, the biologic function of which is largely unknown. Here, we identify and describe the functional role of
Rhophilin-1
as a novel podocyte-specific protein of the kidney glomerulus.
Rhophilin-1
knockout mice were phenotypically normal at birth but developed albuminuria at about 2 weeks of age. Kidneys from severely albuminuric mice revealed widespread podocyte foot process effacement, thickening of the glomerular basement membrane, and FSGS-like lesions. The absence of any overt changes in the expression of podocyte proteins at the onset of
proteinuria
suggested that the primary cause of podocyte abnormalities in Rhpn1-null mice was the result of cell-autonomous,
Rhophilin-1
-dependent signaling events. In culture,
Rhophilin-1
was detected at the plasma membrane leading edge of primary podocytes, where it elicited remodeling of the actin cytoskeleton network. This effect of
Rhophilin-1
on actin cytoskeleton organization associated with inhibitory effects on Rho-dependent phosphorylation of the myosin regulatory light chain and stress fiber formation. Conversely, phosphorylation of myosin regulatory light chain increased in podocyte foot processes of Rhpn1(-/-) mice, implicating altered actinomyosin contractility in foot process effacement and compromised filtration capacity. Targeted deletion of RhoA in podocytes of
Rhophilin-1
knockout mice exacerbated the renal injury. Taken together, our results indicate that
Rhophilin-1
is essential for the integrity of the glomerular filtration barrier and that this protein is a key determinant of podocyte cytoskeleton architecture.
...
PMID:Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration. 2507 Oct 83